Copyright
©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. May 6, 2016; 7(2): 254-260
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.254
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.254
Specific coeliac antibody | Sensitivity % | Specificity % | PPV % | NPV % | AU ROC | LR+2 | LR- |
Single antibody positivity | |||||||
Anti-tTG-IgA1 | 97.7% | 100.0% | 100.0% | 98.0% | 98.9% | - | 0.023 |
Anti-tTG-IgG | 48.0% | 98.0% | 96.0% | 65.3% | 73.0% | 24.000 | 0.531 |
Anti-DPG-IgA1 | 34.1% | 98.0% | 93.8% | 62.8% | 68.1% | 17.045 | 0.673 |
Anti-DPG-IgG | 100.0% | 96.0% | 96.2% | 100.0% | 98.0% | 25.000 | 0.000 |
Combination of two or more positive antibodies | |||||||
Anti-tTG-IgA/-IgG + anti-DGP-IgG/-IgA | 98.0% | 100.0% | 100.0% | 98.0% | 99.0% | - | 0.020 |
- Citation: Konopka E, Grzywnowicz M, Oralewska B, Cielecka-Kuszyk J, Trojanowska I, Cukrowska B. Clinical utility of quantitative multi-antibody Polycheck immunoassays in the diagnosis of coeliac disease. World J Gastrointest Pharmacol Ther 2016; 7(2): 254-260
- URL: https://www.wjgnet.com/2150-5349/full/v7/i2/254.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v7.i2.254